DR. REDDY'S LABORATO

500124
End-of-day quote. End-of-day quote  - 06/18
5284.6INR -0.07%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2020 2021
Net sales1 174 600189 722
EBITDA1 46 43147 480
Operating profit (EBIT)1 28 47031 977
Operating Margin 16,3%16,9%
Pre-Tax Profit (EBT)1 18 03228 324
Net income1 19 49819 149
Net margin 11,2%10,1%
EPS2 117115
Dividend per Share2 25,025,0
Last update 06/09/202005/14/2021
1 INR in Million
2 INR
Estimates
Finances - Leverage
Fiscal Period: March 2020 2021
Net Debt1 --
Net Cash position1 3 7294 265
Leverage (Debt / EBITDA) -0,08x-0,09x
Free Cash Flow1 24 99525 962
ROE (Net Profit / Equities) 13,2%11,6%
Shareholders' equity1 147 589164 985
ROA (Net Profit / Asset) 8,52%7,69%
Assets1 228 823248 866
Book Value Per Share2 9351 052
Cash Flow per Share2 180215
Capex1 4 8469 741
Capex / Sales 2,78%5,13%
Last update 06/09/202005/14/2021
1 INR in Million
2 INR
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 875 196 M INR -
Entreprise Value (EV) 864 463 M INR 850 103 M INR
Valuation 2021e 2022e
P/E ratio (Price / EPS) 36,9x 26,7x
Capitalization / Revenue 4,58x 3,77x
EV / Revenue 4,53x 3,72x
EV / EBITDA 19,3x 15,8x
Yield (DPS / Price) 0,47% 0,54%
Price to book (Price / BVPS) 5,11x 4,34x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 16,4% 17,6%
Operating Leverage (Delta EBIT / Delta Sales) 1,07x 1,41x
Net Margin (Net Profit / Revenue) 11,8% 14,2%
ROA (Net Profit / Asset) 10,6% 13,0%
ROE (Net Profit / Equities) 15,2% 17,2%
Rate of Dividend 17,2% 14,3%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   8,96% 4,42%
Cash Flow / Sales 16,5% 11,8%
Capital Intensity (Assets / Sales) 1,11x 1,09x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend